3860 results for «570»
3860 results
The latest on the prevail drug-coated balloon
18 May 2021 – From EuroPCR 2021
Watch this session presented by Azeem Latib and Antonio Colombo in order to reflect on the latest information on Prevail DCB and study, to explore DCB technology and hear the expert-recommended indications, and to gain insights through an interesting PI case using Prevail DCB.
Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel
26 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to learn and understand how and where to use a Sirolimus DCB in current practice, to see clinical evidences and results for the treatment of Patients with Sirolimus DCB and to see the potential advantages of using the Sirolimus over...
The future of PCI seems bright - The MagicTouch sirolimus-coated balloon
18 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...
Shockwave IVL: a new alternative to alternative TAVI access
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn about new options for alternative TAVI access to cope with most challenges, as well as various approaches to patient selection. Gain insight also into how intravascular lithotripsy may be an option to preserve transfemoral TAVI, with a selection of clinical cases and...
Nothing to fear - a guide to combine DCB and DES in hybrid PCI
19 May 2022 – From EuroPCR 2022
DCB in in-stent restenosis, DCB and DES, DCB in ACS, and a guide to use DCB in de novo lesions and bifurcations: this is the programme of this EuroPCR 2022 session devoted, not surprisingly, to drug-coated balloons.
Restoring vessel physiology and function with Dynamx Bioadaptor - The holy grail of PCI
17 May 2023 – From EuroPCR 2023
Join this session to explore the revolutionary Dynamx Bioadaptor and its role in restoring vessel physiology and function. Learn about the specific patient and lesion characteristics that can be safely and effectively treated with this innovative device, gain confidence in the delivery and deployment techniques, understand...
Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guidewire
16 May 2024 – From EuroPCR 2024
Follow this session to discover how accurate resting index can inform decision-making for DCB in CTO patients and understand the role of physiology in a new PCI workflow for complex MVD. Thus, you will learn about a DCB intention-to-treat strategy guided by post-PCI coronary physiology in...
MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD
19 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Aloke Finn, Sandeep Basavarajaiah, Gianluca Caiazzo and Bernardo Cortese in order to know where to use a DCB in today's clinical practice, to learn about real-world case-based experience and interesting data presentation from various registries and clinical studies, and to understand the technology...
Future and scope of sirolimus-coated balloon in peripheral vascular treatment
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the emerging sirolimus-coated balloon (SCB) technology in peripheral vascular treatment. Discover the SCB with NANOLUTE technology clinical outcome in below-the-knee (BTK) and superficial femoral artery (SFA) indications, and in arteriovenous fistula (AVF) and arteriovenous graft (AVG) indications.
DynamX Bioadaptor, the new frontier beyond stenting for PCI
22 May 2019 – From EuroPCR 2019
Consult this session on DynamX Bioadaptor to learn more about its technological advances and the early clinical trial results including QCA, IVUS and OCT imaging.
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release
18 May 2022 – From EuroPCR 2022
Thanks to this EuroPCR 2022 session, discuss how sustained limus release technology can broaden DEB indications, learn about the decision-making process on the use of DEB adjacent to DES in complex PCI, and review DEB specific implantation techniques to achieve optimal outcomes for the patient.
Innovative devices for innovative procedures
17 May 2022 – From EuroPCR 2022
This session focuses on innovations to invent or improve therapeutic modalities in the cath lab based on unmet needs in PCI, LAAO, CHF interventions, intravascular imaging and therapeutics, TAVI, and peripheral vascular interventions.
RevoEdge high pressure cutting balloon in PCI: innovate, cut, and conquer
20 May 2025 – From EuroPCR 2025
Discover how the next-generation RevoEdge high-pressure cutting balloon is transforming PCI with innovative design and proven clinical outcomes. This session presents a multicenter randomised trial and real-world case discussions, showcasing RevoEdge’s effectiveness in tackling resistant, complex lesions—including long, tortuous, and fibrotic cases. Learn practical tips, tricks,...
Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delivers a comprehensive update on the MagicTouch sirolimus-coated balloon (SCB) and its expanding role in treating both coronary and peripheral artery disease (CAD/PAD). The session covers the extensive clinical trial program supporting MagicTouch as a versatile treatment option across multiple indications. It...
Transforming PCI: mastering the implementation of drug-eluting balloons
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session provides a comprehensive overview of drug-eluting balloons (DEBs) and their growing role in percutaneous coronary intervention (PCI). Gain a clear understanding of the clinical evidence and rationale supporting DEBs, including how these devices minimize metal implantation and effectively treat both standard and...
Empowering DES performance in complex patients to maximise efficacy and safety outcomes
20 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...
TAVI best practice: implementing cusp overlap and commissural alignment
19 May 2022 – From EuroPCR 2022
Watch this session to understand why commissural alignment should become a standard procedure, why cusp overlap is fundamental for self-expandable devices, and why simulation-based learning is an advanced way to reduce the learning curve.
DCB in de novo lesions: new valid option?
20 May 2025 – From EuroPCR 2025
Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.
Sirolimus-coated balloon: expanding the scope of indications for complex coronary artery disease treatment
14 May 2024 – From EuroPCR 2024
Watch this session to gain case-based insights on using DCBs in complex settings. Learn valuable tips and tricks for optimal DCB application, including the best timing and situations for their use. Discover how to effectively implement a hybrid strategy that combines DES and DCB when needed.
